A blood test that names the foods behind your symptoms is an appealing proposition. It offers a list where there was uncertainty. But the important question is whether that list identifies a cause. For commercial IgG food panels, the evidence does not justify treating flagged foods as diagnosed intolerances. A promising IBS trial adds nuance, rather than settling the matter.
What is the test actually measuring?
IgG stands for immunoglobulin G, a type of antibody. Finding it against a food is not the same as finding an allergy. In a 2022 Mayo Clinic explanation by registered dietitians, food-specific IgG is described as reflecting exposure; higher IgG4 levels may be associated with tolerance. That is a very different interpretation from a warning that the food is harming you.
This distinction is the first question to ask of a report: what does its measurement establish? Detecting an antibody and showing that a particular food causes symptoms are separate tasks. The Mayo authors advise against using these panels to diagnose food sensitivities and warn about misdiagnosis. A laboratory result can be technically measurable without supporting the dietary conclusion attached to it.
For someone trying to decide what to eat tomorrow, the useful information is therefore more specific than a positive or negative label. It is whether the method has been shown to identify the condition being investigated, in people like them, and whether acting on it improves outcomes. Those are fair questions to bring to the clinician interpreting any purchased report.
Allergy and intolerance need different questions
The NHS guidance on food intolerance distinguishes intolerance from an immune-system food allergy. Lactose intolerance, for example, concerns difficulty digesting the sugar lactose. Depending on the suspected problem, assessment may involve a food-and-symptom diary, a supervised dietary trial, or a breath test. There is no implication that every digestive symptom has the same cause or needs the same test.
For suspected allergy, the history matters: which food, which symptoms, how soon afterwards, and whether the pattern has happened again. Mayo Clinic’s 2026 diagnostic guidance describes skin-prick and blood testing alongside that assessment. Even a positive allergy test does not necessarily establish that eating the food will cause a clinical reaction. Interpretation remains part of the investigation.
That is why exchanging an IgG panel for a broad allergy panel is not automatically the answer. The appropriate question is which condition the clinician suspects and which investigation can help resolve it. A test ordered to answer a focused question is easier to interpret than a catalogue of results with no clear relationship to symptoms.
A 2025 IBS trial deserves a careful reading
It would be too sweeping to say that no IgG-guided diet has ever shown benefit. In Prashant Singh and colleagues’ 2025 randomised trial in Gastroenterology, 238 people with irritable bowel syndrome were assigned to an experimental diet or a sham elimination diet. The study used a particular 18-food, IBS-specific IgG assay and ran for eight weeks.
In the modified intention-to-treat analysis of 223 participants, 59.6% in the experimental group met the pain-response endpoint, compared with 42.1% in the sham group. The endpoint was at least a 30% reduction in abdominal pain for at least two of the final four weeks. That is a meaningful signal for further research, and the authors called for a larger validation study.
It is also a bounded result. This was symptom research in selected people with IBS, using one assay. It did not establish that every commercial IgG panel diagnoses intolerance, or that flagged foods are allergens. Nor does eight weeks establish lifelong benefit. The editorial judgement here is to keep the finding attached to the population, test, and outcome that were actually studied.
Eliminating food is an intervention too
Avoiding foods can sound like a harmless experiment because it does not involve a medicine. The NHS warns that home tests may lead people to exclude multiple foods and miss vitamins and minerals. It advises speaking to a GP or dietitian before cutting foods out. A restriction needs a nutritional plan, rather than simply a longer shopping list of things to avoid.
There is a psychological cost to consider as well. The Mayo Clinic dietitians’ review describes unnecessary restrictions, anxiety around eating, fear of foods, and poor nutrition as possible consequences of sensitivity testing. Feeling worse around meals is not a trivial side issue when the purpose of the investigation was to improve daily life.
Before agreeing to a dietary trial, useful questions include what will replace the excluded foods, what improvement would count, when the result will be reviewed, and how the next step will be decided. The point is to make the proposed change assessable. An indefinite avoidance list gives neither the patient nor the clinician a clear finish line.
Some situations need particular care
Wheat is a good example of why the sequence matters. NIH’s NIDDK guidance on coeliac diagnosis advises against starting a gluten-free diet before diagnostic testing because it can affect the results. Symptoms alone cannot diagnose coeliac disease. If you have already reduced gluten, tell your clinician rather than attempting to design your own gluten challenge.
Possible allergy calls for a different safeguard. Mayo Clinic describes an oral food challenge as a procedure undertaken by a healthcare team able to recognise and treat reactions, including anaphylaxis. A home sensitivity report is not permission to try a suspected allergen, and a reassuring result should not overturn an existing allergy plan. Seek clinical advice about suspected allergy and follow the avoidance advice already given.
Emergency symptoms: sudden throat or tongue swelling, breathing difficulty, collapse, or marked dizziness after food can indicate anaphylaxis. NHS emergency guidance says to call 999 for suspected anaphylaxis and use a prescribed adrenaline auto-injector if available. Do not wait for a food diary, another blood test, or a routine appointment.
What this means in practice
- Bring an existing test report to a GP or appropriate clinician, and ask what its results can establish before changing your diet.
- Prepare a short account of the foods involved, symptoms, and timing for the appointment, as suggested in Mayo Clinic’s consultation guidance.
- Ask for dietetic help if several foods are being excluded, including a replacement plan and a date to review the restriction.
- Tell the clinician about gluten avoidance before coeliac investigations; agree any further dietary changes with them.
- Keep following an established allergy action plan. Do not use an IgG report to decide that a suspected allergen is safe to challenge at home.
It may help to take three questions into the discussion: what diagnosis is being considered, what evidence supports the proposed test, and what would change after either result? Asking for that explanation does not dismiss symptoms. It keeps the investigation connected to the problem that brought you to seek help.
What we don’t know
The IBS trial leaves questions about replication, sustained benefit, and how its particular assay would compare with other approaches to dietary care. Its results cannot supply those answers for unrelated panels. Meanwhile, an unhelpful commercial test does not explain away someone’s symptoms: it means the investigation still needs to identify the right clinical question.
The reasonable aim is a diet that is safe, adequate, and as unrestricted as the evidence permits. A report earns its place in that decision by helping answer a clinical question, not by producing the longest list of foods to fear.
Photo: Nadine Primeau on Unsplash. Illustrative food photograph; pictured foods are not identified as causes of symptoms.
